SCHEMBL22969845

SCHEMBL22969845

CC(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCC(=O)N(CCN2C(=O)CC(C)C2=O)CCN2C(=O)CC(C)C2=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 1/20 0.39
▸ SIRT1 Q96EB6 2/20 0.38
▸ SIRT2 Q8IXJ6 1/20 0.38
▸ CALCRL Q16602 1/20 0.38
▸ PTGER4 P35408 2/20 0.37
▸ OPRL1 P41146 2/20 0.37
▸ OPRK1 P41145 3/20 0.37
▸ ITGB1 P05556 4/20 0.36
▸ ITGA4 P13612 3/20 0.36
▸ KDM1A O60341 3/20 0.36
▸ MAOA P21397 2/20 0.36
▸ KDM1B Q8NB78 1/20 0.36
▸ RCOR1 Q9UKL0 1/20 0.36
▸ OPRM1 P35372 2/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ NPFFR1 Q9GZQ6 1/20 0.36
▸ NPFFR2 Q9Y5X5 1/20 0.36
▸ SIRT5 Q9NXA8 1/20 0.36
▸ ITGA5 P08648 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22970094 0.94 TACR1 (0.39) TACR1SIRT1SIRT2CALCRLPTGER4
SCHEMBL22969940 0.92 OPRL1 (0.42) SIRT1SIRT2CALCRLOPRL1ITGB1
SCHEMBL23180468 0.91 TACR1 (0.35) TACR1SIRT1SIRT2CALCRLPTGER4
SCHEMBL22969857 0.91 NPY4R (0.41) SIRT1SIRT2CALCRLOPRL1ITGB1
SCHEMBL25100624 0.89 OPRK1 (0.37) TACR1SIRT1SIRT2PTGER4OPRL1
SCHEMBL25100623 0.88 TACR1 (0.39) TACR1SIRT1SIRT2CALCRLPTGER4
SCHEMBL22969859 0.85 KDM1A (0.43) SIRT1SIRT2OPRK1KDM1AMAOA
SCHEMBL25100620 0.83 TACR1 (0.36) TACR1SIRT1SIRT2OPRL1OPRK1
SCHEMBL13477993 0.82 CALCRL (0.49) CALCRLOPRL1OPRK1ITGB1ITGA4
SCHEMBL22970116 0.81 MAP1LC3B (0.40) SIRT1SIRT2OPRL1SIRT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021022678-A1 ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF 烟台迈百瑞国际生物医药股份有限公司 2021-02-11 — — WO disclosed
Send feedback